Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Response to PARP Inhibitor Predicted by the RAD51 Assay (REPAIR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03044795
Recruitment Status : Withdrawn (The study never started)
First Posted : February 7, 2017
Last Update Posted : July 5, 2019
Sponsor:
Collaborators:
AbbVie
Dutch Cancer Society
Information provided by (Responsible Party):
J.A. Gietema, University Medical Center Groningen

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : November 2020